NRC Health Proceeds from Insurance Settlement, Investing Activities
NRC Health (NRC) reported Proceeds from Insurance Settlement, Investing Activities of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromInsuranceSettlementInvestingActivities · last filed 2023-03-03
- NRC Health proceeds from insurance settlement, investing activities for the quarter ending 2020-12-31 was $0.00.
- NRC Health proceeds from insurance settlement, investing activities for fiscal 2020 was $260.00K.
| Period end | Proceeds from Insurance Settlement, Investing Activities 3 month | Proceeds from Insurance Settlement, Investing Activities 9 month | Proceeds from Insurance Settlement, Investing Activities 12 month |
|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $260.00K 10-K · filed 2023-03-03 | |
| 2020-09-30 | $260.00K 10-Q · filed 2021-11-05 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |